Recent advances in healthcare research have increasingly leveraged routinely collected administrative data to monitor cancer recurrence. This approach circumvents the delays and resource-intensive ...
The Signatera assay showed positive correlations between ctDNA presence and cancer recurrence, suggesting its potential for ...